quantisnow
FeedTopReportsPricing
⌘K
Live feed
09:00:52·29d
ANALYSTRating
Novo Nordisk A/S logo

Wolfe Research initiated coverage on Novo Nordisk A/S

NVO· Novo Nordisk A/S
Health Care
Original source

Companies

  • NVO
    Novo Nordisk A/S
    Health Care

Recent analyst ratings

  • Mar 26UpdateWolfe Research-
  • Mar 18UpdateBernstein-
  • Mar 18UpdateBernstein$175.00
  • Mar 10UpdateTD Cowen$42.00
  • Mar 3UpdateMorgan Stanley$40.00
  • Mar 2UpdateGoldman$41.00

Related

  • PR1d
    The Longevity Trade Is No Longer a Buzzword — It's a $120 Billion Market, and the FDA Just Cleared the First Cellular Rejuvenation Trial
  • SEC4d
    SEC Form 6-K filed by Novo Nordisk A/S
  • SEC4d
    SEC Form 6-K filed by Novo Nordisk A/S
  • SEC11d
    SEC Form 6-K filed by Novo Nordisk A/S
  • SEC17d
    SEC Form 6-K filed by Novo Nordisk A/S
  • SEC25d
    SEC Form 6-K filed by Novo Nordisk A/S
  • SEC28d
    SEC Form 6-K filed by Novo Nordisk A/S
  • SEC28d
    SEC Form 6-K filed by Novo Nordisk A/S
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022